InSphero

Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of Excellence™

[InSphero @InSphero]

InSphero is proud to partner with @officialatcc !

Their commitment to quality and consistency is vital for our work, especially with our ARCTis platform. Congrats to ATCC on 100 years of advancing science!

#ATCC100 #Innovation #CellCulture #InSphero

[ATCC @officialatcc]

Jan Lichtenberg, PhD, CEO and co-founder of InSphero, a global leader in scalable, reliable and reproducible 3D cell culture technology shares why ATCC is critical to their success. Learn more about our impact over the last century: https://t.co/clJ6UrdhUZ

[InSphero @InSphero]

InSphero is at HIRN 2025!

HIRN kicks off today in Bethesda, MD, and we’re excited to share our solutions for studying:
✔️ Islet function
✔️ β-cell regeneration & preservation

Chat with our experts and check out our posters on cutting-edge diabetes research. Let’s connect! 🧬

[InSphero @InSphero]

Join us at SLAS 2025 in San Diego, Jan 25–29, at Booth #2623 to explore our innovative 3D cell culture technologies and discover our 96-Well Cryopreserved 3D Human Tumor Spheroid Platform.

Let’s connect and discuss the future of in vitro research!

More details in the comments!

[InSphero @InSphero]

Read the full blog post here: https://t.co/XfuoNafzrb

[InSphero @InSphero]

MPS bridge the gap between animal & human data, reducing live testing & supporting ethical research.

InSphero’s 3D InSight™ XSpecies Liver Microtissues enable precise toxicity testing.

Learn more in the full blog! 🧪 Link below. 👇

[InSphero @InSphero]

✨ Reflecting on a successful ACT 2024! ✨

Thank you to everyone who visited us at booth #503. We loved showcasing our innovations and connecting with you!

Next stop: Society of Toxicology (SOT) 2025 | March 16-20 | Booth #1211 in Orlando. See you there! 👋

[InSphero @InSphero]

Learn more at https://t.co/6hsYqY9xkK

[InSphero @InSphero]

Confused by conflicting DILI data?

InSphero’s 3D InSight™ XSpecies Liver Microtissues help you assess species-specific toxicity and enhance your pre-clinical models.

Compare species to find the best model for your studies.

🔸 Available: Rat, Mouse, Dog, Monkey, Human.

[InSphero @InSphero]

Read the full press release here: https://t.co/v9pX0jRbUI

[InSphero @InSphero]

Proud to support #UNLOOC in revolutionizing drug discovery! 🚀 Through the €68M UNLOOC Chips JU Project, we're advancing #organonchip systems with 3D models & AI for personalized medicine. Partnering with 51 innovators to transform drug safety testing!

Check the comments

[InSphero @InSphero]

Check our activities and book a meeting: https://t.co/NetjSlc0RU

[InSphero @InSphero]

🚨 ACT 2024 is Almost Here! 🚨

Where to find us:
📍 Booth #503 — Discover 3D InSight™ Liver Microtissues!

👩‍🔬 Dr. Colombo | 📅 Nov 18, 5:00 PM | Poster P405
👨‍🔬 Dr. Filippi | 📅 Nov 19, 12:00 PM | Room 204

Meet us—link in comments!

[InSphero @InSphero]

Join our MASH-CALL Initiative in March 2025 to gain insights into:

- Anti-steatotic and anti-fibrotic effects of your compounds
- Comparison with clinical candidates and reference standards

https://t.co/DrXN49PSyV

[InSphero @InSphero]

🎉 AASLD is just days away!

Join us to explore cutting-edge research on anti-fibrotic treatments for #MASH.

📌 Poster Presentations:
Dr. Sue Grepper - Nov 15, 1:00–2:00 pm
Dr. Francisco Verdeguer - Nov 17, 1:00–2:00 pm

[InSphero @InSphero]

Listen to the podcast here: https://t.co/JWabi3JM8H

[InSphero @InSphero]

Catch Dr. Jan Lichtenberg on the second episode of Balancing the Future, the METTLER TOLEDO Laboratory Solutions podcast, as he discusses with Dana and Micah how 3D cell cultures are transforming drug testing and enabling personalized medicine. 🔍

Link in comments! 👇

[InSphero @InSphero]

Check our activities and book a meeting: https://t.co/NetjSlc0RU

[InSphero @InSphero]

Join us at ACT 2024 (Nov 17-20) in Austin! 🌟

Visit Booth #503 & check out Dr. Colombo’s poster on Species-Specific Liver Microtissues (Mon, Nov 18 | 5-6:30 PM, Poster #P405).

Learn how InSphero’s 3D InSight™ is revolutionizing liver toxicity testing.

See you there! 🌵

[InSphero @InSphero]

Can’t make it? Catch us at:
📍ACT 2024 | Nov 17-20 | Booth #503
📍SOT 2025 | Mar 16-20 | Booth #1211

Check our activities at ACT and book a meeting: https://t.co/NetjSlcyHs We’d love to connect!

[InSphero @InSphero]

Our BD Manager, Dr. Arnab China, will be at the MASOT 2024 Fall Meeting on Nov 12 at Kean University, NJ. Join him from 1:15 - 2:15 PM for his poster, “Early Detection of Hepatotoxic Compounds” and learn how our liver microtissues can enhance your research!